Diagnos Laboratorium Utama Tbk. vs Krida Jaringan Nusantara Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp228 (market cap 319B, 124.3K 24h volume), while Krida Jaringan Nusantara Tbk trades at Rp160 (market cap 79B, 8.28M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 4× Krida Jaringan Nusantara Tbk's market cap, and Krida Jaringan Nusantara Tbk is more actively traded (8.28M versus 124.3K). Which is the better fit depends on your goals.
| DGNS | KJEN | |
|---|---|---|
Market Cap | 319B | 79B |
Volume | 124.3K | 8.28M |
Lot | 1.24K | 82.81K |
Turnover | 28.28M | 1.34B |
Average Price | 227.48 | 161.75 |
Value | 28.28M | 1.34B |
Indicative Equilibrium Price | 228 | 160 |
Indicative Equilibrium Volume | 100 | 3.6K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Krida Jaringan Nusantara Tbk (the Company) was established in Jakarta based on the NotarialDeed No. 5 dated October 1, 1998 of Saal Bumela, S.H., Notary in Jakarta.
Read more on KJEN →